It's hard to pick winners in such a long-running bull market, but we think investors who bet on an improving economy and venture overseas will prosper.
We see more gains ahead for these five stocks, in 2017 and beyond.
Data is as of April 30, 2017. Click on symbol links in each slide for current share prices and more.
Bank of America
It took most of a decade for Bank of America (symbol BAC, $23) to put the financial crisis behind it. Now, streamlined operations and implementation of more-conservative lending standards are paying off. In 2016, BofA borrowers had an average FICO credit score of 750, some 50 points higher than the average American’s. Revenues from trading, investment banking and credit cards are strong. Federal Reserve interest-rate hikes should boost interest income by 7% this year, says research firm CFRA. Brokerage firm Credit Suisse sees profits rising by 20% this year and 17% in 2018.
Sponsored Content
CBS
Media conglomerate CBS (CBS, $67) has spun off its radio and outdoor ad businesses to focus on faster-growing and more-profitable lines, including global TV syndication, licensing fees from pay-TV operators and fees from stations for the rights to CBS programming. The company has made digital inroads with subscription access to NFL games and content—including The Good Fight and the upcoming Star Trek: Discovery—that is available only online. Midterm elections will boost ad sales in 2018. Brokerage UBS sees earnings growth of 9% this year and 15% in 2018.
Sponsored Content
Cummins
- Cummins (CMI, $151) makes diesel and natural gas engines, power-generation systems, and engine-related components. The company is benefiting from increasing demand in China, a recovery in the energy sector, and favorable prospects for infrastructure spending and emissions controls here and abroad. CFRA sees Cummins’s earnings rising by 18% this year and 13% in 2018 and calls the stock a “strong buy.” The shares yield 2.7%.
Sponsored Content
Over in Europe
European bargains include Germany’s Bayer (BAYRY, $124), a drug and crop-science company, and French pharmaceutical firm Sanofi (SNY, $47). Worries about the prospects for Sanofi’s diabetes franchise are pressuring the stock, but the company’s reach in emerging markets is promising, says Vincent Montemaggiore, manager of Fidelity Overseas Fund. He also says that Bayer’s pending $66 billion acquisition of Monsanto should lead to steadier earnings, helping to offset the perennial problem of patent expirations in Bayer’s drug business.
Sponsored Content
-
Stock Market Today: Stocks Stabilize After Powell's Rate-Cut WarningThe main indexes temporarily tumbled after Fed Chair Powell said interest rates could stay higher for longer.
-
Bank of America Gets Downgraded Ahead of Earnings: What You Need to KnowBank of America’s stock is now at fair value, UBS says. Here’s what you need to know.
-
How Inflation, Deflation and Other 'Flations' Impact Your Stock PortfolioThere are five different types of "flations" that not only impact the economy, but also your investment returns. Here's how to adjust your portfolio for each one.
-
Warren Buffett Stocks: Analyzing The Berkshire Hathaway PortfolioThe Berkshire Hathaway portfolio is a diverse set of blue chips and some lesser-known growth bets. Here, we look at all stocks picked by Buffett and his lieutenants.
-
Kiplinger's Economic Calendar for This Week (April 15-19)Check out our economic calendar for this week, as well as our previews and recaps of the more noteworthy reports.
-
Why I Still Won't Buy Gold: GlassmanOne reason I won't buy gold is because while stocks rise briskly over time – not every month or year, but certainly every decade – gold does not.
-
Should You Use a 25x4 Portfolio Allocation?The 25x4 portfolio is supposed to be the new 60/40. Should you bite?
-
Retirement Income Funds to Keep Cash Flowing In Your Golden YearsThe stars are aligning for retirement income funds, which are aimed to engineer a steady payout of cash for retirees.
